HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985–2015
| Autor: | Jannie J. van der Helm, Karen Lindenburg, Maarten F. Schim van der Loeff, Maria Prins, Daniela K van Santen |
|---|---|
| Přispěvatelé: | AII - Infectious diseases, APH - Global Health, Graduate School, Other departments, Infectious diseases, Amsterdam institute for Infection and Immunity |
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male Cart medicine.medical_specialty HIV seroconversion Human immunodeficiency virus (HIV) 030508 substance abuse Medicine (miscellaneous) HIV Infections medicine.disease_cause Drug Users 03 medical and health sciences 0302 clinical medicine Risk groups Internal medicine medicine Humans 030212 general & internal medicine Netherlands business.industry Health Policy Medical record virus diseases Hepatitis C Patient Acceptance of Health Care medicine.disease Antiretroviral therapy Virology digestive system diseases Female 0305 other medical science business Cohort study |
| Zdroj: | International journal on drug policy, 47, 95-101. Elsevier |
| ISSN: | 0955-3959 1873-4758 |
| DOI: | 10.1016/j.drugpo.2017.05.026 |
| Popis: | Background: HIV-positive people who use drugs (PWUD) start antiretroviral therapy (ART) later than other risk groups, and among HCV-positive PWUD, HCV treatment uptake is low. Nowadays, HCV direct acting antivirals (DAAs) are available and reimbursed in the Netherlands (since 2014). The Amsterdam Cohort Studies (ACS), initiated in 1985, provides us the opportunity to describe temporal trends in ART and HCV-treatment uptake among PWUD through 2015. Methods: We analyzed data from PWUD participating in the ACS between 1985 and 2015. ART and HCV-treatment data were obtained from ACS questionnaires and medical records. Treatment uptake was defined by: treatment initiation (the proportion initiating any kind of ART/HCV treatment when treatment-naive) and coverage (the proportion ever treated for HIV/HCV) among all HIV-/HCV-RNA-positive PWUD. Each was calculated per calendar year. We estimated the cumulative probability of ART uptake in the pre-cART ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect